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Background
The HeartMate II Left Ventricular Assist Device (LVAD) receives power via a
percutaneous lead connected to an external controller and batteries. At times, this
lead can be damaged during normal wear, as well as by traumatic fracture, which
may jeopardize the functionality of the LVAD. If there is significant internal
damage, surgical replacement of the LVAD is required. However it is possible to
repair externally damaged leads by replacing the distal portion of the lead to avoid
pump replacement. We report the overall experience and outcomes in patients
with external lead repairs.
Methods
A procedure for full external lead replacement has been developed and is
approved for implementation by the FDA. Pre-procedural steps include
examination of high resolution x-rays of the driveline and analysis of pump log
files. Efficacy and outcomes of all attempted external lead repairs were evaluated
between initiation of repairs in 2008 through 2014.
Results
A total of 321 repairs were attempted in 297 patients with suspected isolated
external lead damage after a median of 2.0 yr [range: 7d to 8.7 yr] of support. Of
297 patients, 37 (12.5%) had attempts at external repair that were unsuccessful
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due to concomitant internal lead damage. 31 patients (10.4%) had additional
serious malfunctions after lead repair resulting in 17 with repeat repairs and 14
who continued on ungrounded cables, and ultimately 14 of these 31 patients
required pump exchanges. 27 of the 297 patients (9.1%) with lead repairs had only
minor additional problems, including cuts or abrasion in the insulation which was
fixed with tape or external reinforcement. There was one catastrophic failure
during attempted lead repair requiring emergent pump exchange, and there were
three deaths within 14 days of attempted repair related to continued percutaneous
lead damage. One of these patients refused pump exchange, and two were not
candidates for other clinical reasons. 202 of the 297 patients (68%) have had no
recurrence of lead problems after a median follow-up of 189 days [n=11 over 2
years, longest 5.8 yr].
Conclusions
HeartMate II dysfunction due to percutaneous lead damage is uncommon but is of
serious concern due to potential abrupt pump stoppage. Lead repair by
replacement of the external distal percutaneous lead can be performed by trained
personnel in a standardized fashion and may provide a durable solution in select
patients with isolated external lead damage, thus avoiding the need for surgical
pump exchange. We provide an algorithm for evaluating potential lead damage.
Keywords: LVAD, percutaneous lead, repair, ventricular assist device

Background
The HeartMate II (St Jude Medical, Pleasanton, CA, previously Thoratec
Corporation) is currently the only left ventricular assist device approved by the
FDA for both bridge to heart transplantation and destination therapy. The pivotal
trials for bridge to transplantation and destination therapy demonstrated
significantly improved reliability compared to earlier pulsatile volume displacement
devices and minimal bearing wear in explanted pumps1–3. To date, over 20,000
implants have been performed worldwide, and nearly 8,000 patients remain on
support. With an increasing proportion of patients being implanted as destination
therapy with longer durations of support, physical wear on the external
components are emerging as a factor in long-term durability. The HeartMate II
LVAD, like other LVADs, is dependent on the externalized lead for electrical power
and control of pump settings. The percutaneous lead is susceptible to physical
damage, which may manifest as pump speed or power fluctuations, alarms, device
malfunction, or at worst, potentially catastrophic abrupt pump stoppage. Due to
these limitations, a new pump design of the HeartMate 3 has incorporated
modularity in the external lead to mitigate this possibility4.
The HeartMate II percutaneous lead consists of three pairs of redundant wires that
are electrically shielded and protected by two water-resistant jackets (Figure 1).
The internal wiring schematic is shown in Figure 2. Damage to the external lead by
repeated flexion can be manifested by retraction of the silver-coated copper
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braided shield and fracture of an individual wire (Figure 3). Damage to the braided
shield without internal wire fracture, can lead to a phenomenon known as short-toshield, which can result in pump dysfunction when connected to a grounded power
source5. There is also the possibility of a short between two different motor leads
by the shield wires which cause pump stoppage even if a non-grounded shield
cable is used.

Figure 1: Schematic of HeartMate II percutaneous lead

Figure 2: Internal wiring diagram of HeartMate II percutaneous lead
Black

Motor

Brown
Green
Yellow
Orange
Red

Shield

Traditionally, damage to the external lead not resulting in pump dysfunction was
treated by external reinforcement of the driveline. Damage of the driveline causing
abnormal LVAD function typically required LVAD exchange, usually through a
repeat sternotomy, but more recently via a subcostal approach6–14. In 2009,
Thoratec (St. Jude) developed a procedure for external driveline repair to reduce
the need for pump exchange procedures. We reviewed the aggregate clinical
experience to date of external driveline repairs of HeartMate II LVADs.
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Figure 3: Damage to the external lead by repeated flexion can be manifested by
retraction of the silver-coated copper braided shield and fracture of an individual
wire (orange).

Methods
A retrospective review was undertaken of all percutaneous lead repairs performed
by the St Jude Medical Technical Services Team. The HeartMate II log file for
each patient was reviewed for alarms, unexplained pump stoppages, pump speed
and/or power fluctuations. Each patient initially underwent a controller exchange
and close examination of visible connectors to ensure adequate contact. A
radiograph of the externalized portion of the percutaneous lead was obtained, and
examined for evidence of broken wires or abnormal shielding. If external damage
was identified (Figure 4), preparation for repair by St. Jude Medical personnel was
undertaken.
A procedure for external percutaneous lead replacement was developed and
approved for implementation by the U.S. Food and Drug Administration. The repair
technique involves removing the silastic covering from the driveline, separating
each pair of wires, and splicing a new lead to the damaged set of wires (Figure 5).
The pump continues to function on the intact wires of the original lead. The new
lead is then tested, and control transferred to the new controller. The second set of
wires is then transferred to the new lead, and the repaired section is re-insulated
and encapsulated in a water-resistant enclosure (Figure 6). Of note, the external
percutaneous lead repair requires approximately 15cm from the skin exit site, and
must not include any velour-covered areas.
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Patients who underwent external driveline replacement were then followed
clinically to determine success of repair, durability, and potential need for further
intervention on the percutaneous lead or pump exchange.
Figure 4: Radiographs of lead damage

Figure 5: Repair of external percutaneous lead
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Figure 6: Completed percutaneous lead repair

Results
Between January 1, 2008, when the external percutaneous lead repair procedure
was initiated, until December 31, 2014, a total of 321 repairs were undertaken in
297 patients. The median duration of mechanical support prior to the repair
procedure was 2.0 years (range 7days -8.7 years). 202 of the 297 (68%) patients
had resolution of pump dysfunction with no recurrence of lead problems. The
median duration of support after lead replacement was 189 days, with 11 patients
greater than two years. Twenty-seven of 297 (9.2%) of patients had minor
additional problems such as abrasions of the insulation without electrical damage
that were repaired with tape and external reinforcement.
Thirty-seven (12.5%) patients had unsuccessful external replacement of the
percutaneous lead due to concomitant intracorporeal lead damage. Thirty-one
(10.4%) patients continued with serious malfunctions after lead replacement. Of
these, 17 patients underwent repeat repair, and 14 continued on ungrounded
cables. Fourteen of these 31 patients ultimately underwent pump exchange (Table
1).
One patient required emergent pump exchange due to catastrophic failure during
the external lead replacement procedure. In this specific instance, there was a
concomitant internal driveline fracture that had not been detected prior to external
repair. There were three deaths within 14 days of attempted lead repair due to
ongoing lead damage and electrical malfunction of the LVAD. One patient refused
pump exchange, and the other two were deemed not candidates for repair due to
clinical reasons.
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Table 1:
Repair Outcome

Number (%)

Successful without additional intervention

202 (68)

Successful with minor additional repair

27 (9.1)

Additional serious malfunctions

31 (10.4)

Repeat Repair

17

Continue support on ungrounded cable

14

Unsuccessful

37 (12.5)

Discussion
Since approval of the HeartMate II LVAD in 2008, more than 20,000 implants have
been performed. During this period, an increasing number of patients are
implanted as Destination Therapy, and extended durations of support are
becoming the norm. This has led to longer time periods during which the external
percutaneous lead is exposed to physical damage.
Early experience with external percutaneous lead failures were exclusively treated
with urgent pump exchange procedures15. While exchange procedures can
typically be performed safely, there remains additional risk from the repeat surgical
procedure, as well as the financial impact of that care episode. Stulak and
colleagues reported on a series of LVAD exchanges and found that while the
operative mortality was encouragingly low (3.5%), patients were at risk for late
mortality, increased morbidity and frequently repeated device exchange16. In
addition, Moazami et al reported on a series of LVAD exchanges, and found that
30% of patients ultimately died within one year of pump exchange17. Despite this,
Anand et al found that pump exchange prolonged support time in a manner similar
to the original implant18. Kalavrouziotis and colleagues recently reported on the
incidence of percutaneous lead failures among patients supported with HeartMate
II LVADs and found that 9.2% of implanted pumps developed lead damage19. They
concluded that lead failures played a significant role in the long-term durability of
left ventricular assist devices. Two significant revisions in the percutaneous lead
design, in 2007 and 2012, have reduced the incidence of lead failure.
We report on the external percutaneous lead repair technique and associated
long-term outcomes of patients supported on repaired leads. Isolated external lead
damage can be successfully repaired in a significant number of patients, thereby
avoiding the morbidity and mortality risk of a pump-exchange procedure. In some
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patients, additional minor repairs (such as external reinforcement) are necessary,
while others may require more extensive additional repair. In rare occasions, a
patient is maintained on an ungrounded cable to prevent short-to-shield
phenomena. The incidence of abrupt pump stoppage during the repair procedure
is exceedingly rare.
A cohort of patients experienced ongoing pump dysfunction after lead repair,
necessitating LVAD exchange. This could be due to concomitant intracorporeal
lead fracture, or other electrical damage not grossly visible on examination of the
driveline. Therefore, we recommend comprehensive and careful radiographic
evaluation to ensure that the intracorporeal portion of the percutaneous lead is
intact, and that areas not easily visible on radiographs are directly examined prior
to proceeding with external percutaneous lead repair.
Our algorithm to evaluate suspected percutaneous lead damage is to analyze the
pump log files for evidence of pump speed or power fluctuations, unexplained
pump stoppage, or alarms (Figure 7). If concern exists for an electrical malfunction
of the left ventricular assist system, comprehensive radiographs are obtained of
the external component of the driveline. Computed tomography may be required
for evaluation of the internal portion of the percutaneous lead. If a lead fracture if
the external part is identified, the St Jude Medical Technical Services Team is
called to perform an external lead repair. Internal lead damage must be excluded
prior to external repair to avoid the possibility of abrupt pump stoppage during
repair or persistent pump malfunction. We perform the repair procedure in patient’s
room in an intermediate care telemetry unit or intensive care unit. Given the low
likelihood of pump stoppage, we do not routinely take precautions, such as
surgical stand-by for emergent pump exchange.

Limitations
The true denominator of percutaneous lead failures may be underestimated by this
methodology. Additionally, since this procedure is relatively recent in the history of
the HeartMate II, there were patients who underwent pump exchange despite
having repairable external leads. Further, since there are regions of the
percutaneous lead that are not easily visible on radiographic examination, there
may be additional patients who may have benefitted from this repair technique.

Conclusions
Replacement of the external percutaneous lead by the St Jude Medical Technical
Support Team can be performed safely, and in most instances, can resolve
electrical malfunction of the LVAD associated with a fracture in the external
component of the lead, and in the absence of an internal lead fracture. This repair
has been shown to be effective and durable. In patients with no evidence of
internal lead fracture, and in whom other causes of electrical failure have been
excluded, we believe that external lead repair should be attempted prior to pump
exchange.
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Figure 7: Algorithm
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